Compare COLD & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COLD | BLLN |
|---|---|---|
| Founded | 1903 | 2016 |
| Country | United States | United States |
| Employees | 12690 | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.3B |
| IPO Year | 2009 | N/A |
| Metric | COLD | BLLN |
|---|---|---|
| Price | $11.83 | $67.09 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 13 | 7 |
| Target Price | $15.38 | ★ $129.57 |
| AVG Volume (30 Days) | ★ 4.7M | 293.3K |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 7.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,601,846,000.00 | N/A |
| Revenue This Year | N/A | $35.42 |
| Revenue Next Year | $2.66 | $32.30 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.10 | $66.00 |
| 52 Week High | $22.36 | $138.70 |
| Indicator | COLD | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 37.53 | 35.90 |
| Support Level | $10.31 | $66.00 |
| Resistance Level | $13.44 | $100.28 |
| Average True Range (ATR) | 0.41 | 7.42 |
| MACD | -0.13 | -0.80 |
| Stochastic Oscillator | 6.87 | 9.38 |
Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.